Closing The Marketing Strategy Tactics-Gap: An Institutional Theory Analysis Of Pharmaceutical Value Chain
Contribution to Books
Innovation and Marketing in the Pharmaceutical Industry
This chapter identifies a strategy-tactics gap in most previous studies of pharmaceutical marketing, and addresses it by systematically analyzing the marketing strategies used in practice with the help of a unique dataset of court discovery documents unsealed in a recent litigation. Adopting an institutional theory perspective, we examine the dominant logic that underlies pharmaceutical marketing strategies, and contrast it with the organizing logics of the value chain partners. Four distinct marketing strategies with carefully crafted interdependencies emerge from our analysis: (1) market penetration strategy involving a focus on segmentation and penetration, (2) evidence-based strategy involving production of science, (3) medical education strategy involving development and dissemination of standards of care, and (4) surrogate selling strategy involving leverage of peer-to-peer influence among target physicians. Together, the strategies uncovered in our analysis provide coherence to the observed marketing tactics and show that they are largely consistent with the logic of consequences which conflicts with the logic of appropriateness guiding the actions of the value chain partners. The institutional theory analysis shows that: (1) pharmaceutical value chain is characterized by conflicted logics, (2) that are amplified by pharmaceutical marketing strategies thereby, (3) inviting regulatory intervention to constrain and restrict pharmaceutical marketing efforts. We propose an open systems framework that elaborates on value chain interdependencies and compare it with the economic framework that characterizes most current research. We close the chapter with an agenda for future research into the theory and practice of pharmaceutical marketing.
Singh, J. & Jayanti, R.K. (2014) Closing the marketing strategy-tactics gap: An institutional theory analysis of pharmaceutical value chain. In M. Ding, J. Eliashberg, & S. Stremersch (Eds.) Innovation and marketing in the pharmaceutical industry: Emerging practices, research, and policies, pp. 701-735. New York, NY: Springer. doi: 10.1007/978-1-4614-7801-0_24
This document is currently not available here.